Pay attention to impulsivity: Modelling low attentive and high impulsive subtypes of adult ADHD in the 5-choice continuous performance task (5C-CPT) in female rats

European Neuropsychopharmacology

Volumn 24, Issue 8, 2014, Pages 1371-1380

  Tomlinson, Anneka ^a   Grayson, Ben ^a   Marsh, Samuel ^a   Harte, Michael K ^a   Barnes, Samuel A ^b   Marshall, Kay M ^a   Neill, Joanna C ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal model; Atomoxetine; Cognition; Dopamine; Methylphenidate; Noradrenaline

Indexed keywords

ATOMOXETINE; METHYLPHENIDATE; CENTRAL STIMULANT AGENT; PROPYLAMINE;

5 CHOICE CONTINUOUS PERFORMANCE TASK; ADULT; ALERTNESS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPARATIVE EFFECTIVENESS; CONTINUOUS PERFORMANCE TEST; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IMPULSIVENESS; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOPHARMACOTHERAPY; RAT; RESPONSE TIME; ANALYSIS OF VARIANCE; ANIMAL; DECISION MAKING; DISEASE MODEL; DRUG EFFECTS; PATHOPHYSIOLOGY; PHYSIOLOGY; REACTION TIME;

ANALYSIS OF VARIANCE; ANIMALS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHOICE BEHAVIOR; DISEASE MODELS, ANIMAL; FEMALE; IMPULSIVE BEHAVIOR; METHYLPHENIDATE; PROPYLAMINES; RATS; REACTION TIME;

EID: 84904986160     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2014.04.008     Document Type: Article

References (46)

1. Arnsten A.F., Scahill L., Findling R.L. Alpha-2-adrenergic receptor agonist for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data. J. Child Adolesc. Psychopharmacol. 2007, 17:393-406.
2. Aron A.R., Russell P.R. the cognitive neuroscience of response inhibition: Relevance for genetic research in attention deficit hyperactivity disorder. Biol. Psychiatry 2005, 57:1285-1292.
3. Asherson P., Adamou M., Bolea B., Muller U., Morua S.,D., Pitts S., Thome J., Young S. Is ADHD a valid diagnosis in adults? Yes. Br. Med. J. 2010, 340:736-737.
4. Bari A., Dalley J.W., Robbins T.W. The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats. Nat. Protoc. 2008, 3:759-767.
5. Barnes S.A., Young J.W., Neill J.C. D1 receptor activation improves vigilance in rats as measured by the 5-choice continuous performance test. Psychopharmacology 2012, 220:129-144.
6. Barnes S.A., Young J.W., Neill J.C. Rats tested after a washout period from sub-chronic PCP administration exhibited impaired performance in the 5-Choice Continuous Performance Test (5C-CPT) when the attentional load was increased. Neuropharmacolgy 2012, 62:1432-1441.
7. Biederman J., Faraone S., Mick E. Age dependant decline of ADHD symptoms revisited: Impact of remission definition and symptom subtype. Am. J. Psychiatry 2000, 157:816-817.
8. Blondeau C., Dellu-Hagedom F. Dimensional analysis of ADHD subtypes in rats. Biol. Psychiatry 2007, 61:1340-1350.
9. Bymaster F.P., Katner J.S., Nelson D.L., Hemrick-Luecke S.K., Threlkeld P.G., Heiligenstein J.H. Atomoxetine increases extracellular levels of norepinephrine and dopamine in the prefrontal cortex of the rat: a potential mechanism for efficacy in attention-deficit/hyperactivity disorder. Neuropsychopharmacology 2002, 27:699-711.
10. Byrne J.H., Voogt M., Turner K.M., Eyles D.W., McGrath J.J., Burne T.H. The impact of adult vitamin D deficiency on behvaiour and brain function in male Sprague-Dawley rats. PLoS One 2013, 9:e71593.
11. Castellanos F.X., Tannock R. Neuroscience of attention-deficit hyperactivity disorder: the search for endophenotypes. Nat. Rev. Neurosci. 2002, 3:617-628.
12. Collings R.D. Differences between ADHD Inattentive and Combined subtypes on the CPT. Behav. Assess. 2003, 25:177-189.
13. Coogan A.N., Dobrean A., Donev R.M., Mateescu L., Muller U., Thome J., Voinescu B.I. Adult attention deficit hyperactivity disorder: translating research in practice. ADHD Atten. Defic. Hyperact. Disord. 2012, 4:41-51.
14. Crosbie J., Perusse D., Barr C.L., Schachar R.J. Validating psychiatric endophenotypes inhibitory control and attention deficit hyperactivity disorder. Neurosci. Biobehav. Rev. 2008, 32:40-55.
15. Cynthia L., Huang-Pollock, Karalunas S., Tam H., Moore A.M. Evaluating vigilance deficits in ADHD: a meta-analysis of CPT performance. J. Abnorm. Psychol. 2012, 121:360-371.
16. Dalley J.W., Fryer T.D., Brichard L., Robinson E.S., Theobald D.E., Laane K. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315:1267-1270.
17. Faraone S., Biederman B., Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol. Med. 2006, 36:159-165.
18. Faraone S.V., Biederman J., Spencer T., Wilens T., Seiden L.J., Mick E., Doyle A.E. Attention-deficit/hyperactivity disorder in adults: an overview. Biol. Psychiatry 2000, 48:9-20.
19. Fayyad J., de Graff R., Kessler R.C., Alonso J., Angermeyer M., Demyttenaere K., Girolamo G., Haro J.M., Karam E.G., Lara C. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br. J. Psychiatry 2007, 190:402-409.
20. Fernando A.B.P., Economidou D., Theobald D.E., Zou M.F., Newman A.H., Spoelder M., Caprioli D., Moreno M., Robbins T.W., Dalley J.W. Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists. Psychopharmacology 2012, 219:341-352.
21. Gibbins C., Weiss M.D., Goodman D.W., Landgraf J.M. ADHD-hyperactive/impulsive subtype in adults. Ment. Illn. 2010, 2:41-45.
22. Groman S.M., James A.S., Jentsch J.D. Poor response inhibition: at the nexus between substance abuse and attention deficit/hyperactivity disorder. Neurosci. Biobehav. Rev. 2009, 33:690-698.
23. Jupp B., Caprioli D., Dalley J.W. Highly impulsive rats: modelling an endophenotype to determine the neurobiological, genetic and environmental mechanisms of addiction. Dis. Models Mech. 2013, 6:302-311.
24. Kessler R.C., Adler L., Ames M., Barkley R.A., Birnbaum H., Greenberg P., Johnston J.A., Spencer T., Ustun T.B. The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J. Occup. Environ. Med. 2005, 47:565-572.
25. Kuntsi J., McLoughlin G., Asherson P. Attention deficit hyperactivity disorder. Neuromol. Med. 2006, 8:461-484.
26. McKenna B.S., Young J.W., Dawes S.E., Asgaard G.L., Eyler L.T. Bridging the bench to bedside gap: validation of a reverse-translated rodent continuous performance test using functional magnetic resonance imaging. Neuroimaging 2013, 212:183-191.
27. Navarra R., Graf R., Huang Y., Logue S., Comery T., Hughes Z. Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:34-41.
28. Paterson N.E., Ricciardi J., Wetzler C., Hanania T. Sub-optimal performance in the 5-choice serial reaction time task was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone. Neurosci. Res. 2011, 69:41-50.
29. Puumala T., Riekkinen P., Sirvio J. Modulation of vigilance and behavioural activation by alpha-1 adrenoceptors in the rat. Pharmacol. Biochem. Behav. 1997, 56:705-712.
30. Puumala T., Ruotsalainen S., Jakala P., Rickkinen P., Sirvio J. Behavioural and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder. Neurobiol. Learn. Mem. 1996, 66:198-211.
31. Puumala T., Sirvio J. Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attentional task. Neuroscience 1998, 83:489-499.
32. Riccio C.A., Reynolds C.R. Continuous performance tests are sensitive to ADHD in adults but lack specificity: a review and critique for differential diagnosis. Int. J. Wasserstein 2001, 113-139.
33. Riccio C.A., Reynolds C.R., Lowe P., Moore J.J. The continuous performance test: a window on the neural substrates of attention. Arch. Clin. Neuropsychol. 2002, 17:235-272.
34. Robbins T.W. The 5-choice serial reaction time task: bahavioural pharmacology and functional neurochenmistry. Psychopharmacology 2002, 163:362-380.
35. Robbins T.W., Arnsten A.F. The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu. Rev. Neurosci. 2009, 53:267-287.
36. Robbins T.W., Everitt B.J. A role for mesencephalic dopamine activation: commentary on Berridge (2006). Psychopharmacology 2007, 191:433-437.
37. Robinson E.S. Blockade of noradrenaline re-uptake sites improves accuracy and impulse control in rats performing a five-choice serial reaction time task. Psychopharmacology 2012, 219:303-312.
38. Robinson E.S., Eagle D.M., Economidou D., Theobald D.E., Mar D.E., Murphy A.C. Behavioural charactisation of high impulsivity on the 5-choice serial reaction time task: specific deficits in 'waiting' versus 'stopping'. Behav. Brain Res. 2009, 196:310-316.
39. Robinson E.S., Eagle D.M., Mar A.C., Bari A., Banerjee G., Jiang X., Dalley J.W., Robbins T.W. Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropharmacolgy 2008, 33:1028-1037.
40. Simon V., Czobor P., Balint S., Meszaros A., Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br. J. Psychiatry 2009, 194:204-211.
41. Swanson J.M., Sergeant J.A., Taylor E., Sonuga-Barke E.J., Jenson P.S., Cantwell D.P. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998, 351:429-433.
42. Teicher M.H., Lowen S.B., Polcari A., Foley M., McGreenery C.E. Novel stratergy for the analysis of CPT data provides new insight into the effects of methylphenidate on attentional states in children with ADHD. J. Adolesc. Psychopharmacol. 2004, 14:219-232.
43. Tzavara E.T., Bymaster F.P., Overshiner C.D., Perry K.W., Wolff M., Witkin J.M., Nomikos G.G. Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitior atomoxtine. Mol. Psychiatry 2006, 11:187-195.
44. Young J.W., Geyer M.A., Rissling A.J., Sharp R.F., Eyler L.T., Asgaard G.L., Light G.A. Reverse translation of the rodent 5C-CPT reveals that impaired attention of people with schizophrenia is similiar to scopolamine-induced deficits in mice. Transl. Psychiatry 2013, 3:e324.
45. Young J.W., Light G.A., Marston H.M., Sharp R., Geyer M.A. The 5-choice continuous performace test: evidence for a translational test of vigilance for mice. PLos One 2009, 4:e4227.
46. Young J.W., Powell S.B., Scott C.N., Zhou X., Geyer M.A. The effect of reduced dopmaine D4 receptor expression in the 5-choice continuous performance task: separating response inhibition from premature responding. Behav. Brain Res. 2011, 222:183-192.